Official LinkedIn Announcement
ParaNano Secures $500K Grant from Oklahoma Center for the Advancement of Science and Technology (OCAST) to Advance Bio-Z™ Smart Bandage Innovation.
We are thrilled to share that ParaNano has been awarded a $500,000 grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST). Being selected as one of only 16 recipients of this prestigious award is a tremendous honor.
Our winning project, “Pilot Manufacturing Process Validation for the Bio-Z™ Smart Bandage,” focuses on establishing a robust manufacturing infrastructure and finishing our FDA pathway. This initiative not only represents a critical milestone for our company but also brings significant benefits to the state of Oklahoma, including job creation and contributing to the growth of its life sciences sector.
ParaNano is the first startup company spun out of the University of Central Oklahoma and has received continuing support. “As Oklahoma’s only metropolitan university, the University of Central Oklahoma is uniquely positioned to collaborate with businesses like ParaNano, driving innovation that moves our community forward. The partnership with ParaNano is particularly special because it is our own alumni working with our faculty to create solutions that better the lives of others. We’re excited that OCAST has recognized the importance of ParaNano’s work, and we look forward to their continued growth and success,” said UCO President Todd G. Lamb.
Chronic wounds pose a major challenge in healthcare, with infections often leading to severe complications and delayed recovery. Current monitoring methods are largely reactive, detecting issues only after infections have advanced. This highlights the urgent need for proactive solutions to improve patient outcomes.
The Bio-Z™ Smart Bandage is designed to address this need through continuous, non-invasive monitoring of chronic wounds. Its innovative technology visually indicates infection through a color change, empowering clinicians with timely insights to intervene early and reduce wound-related complications.
We are excited to continue driving innovation in healthcare and are deeply grateful to the Oklahoma Center for the Advancement of Science and Technology (OCAST) and our partners for supporting this transformative work.
